Head-to-head · WeighScore
Avono Health vs OurView Health
By GLP-1 ScorecardUpdated
Score comparison
OurView Health has the higher recorded score — 67.6/100 to 58.7/100.
OurView Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.
Before you choose
Before comparing the headline prices, the Avono Health review and the OurView Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Avono Health vs Revel RX and Candor Rx vs OurView Health compare each of them with another graded program, and the list of alternatives to Avono Health ranks the programs closest to Avono Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Avono Health | OurView Health |
|---|---|---|
| WeighScore | 58.7/100 | 67.6/100 |
| Grade | C | C |
| Site position | #395 | #175 |
| Semaglutide | $79/mo (compounded injection) | $75/mo (starting dose, compounded) |
| Tirzepatide | $139/mo (compounded injection) | $135/mo (starting dose, compounded) |
| Coverage | Availability varies by treatment and state | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Advertises the same price across the listed doses for each injection
- No separate clinician or membership fee advertised
- Describes the intake authorization separately from the completed charge
What to consider
- Cancellation cutoff depends on the selected plan and processing status
- Refunds are limited once clinical review or fulfillment has progressed
- Availability varies by treatment and state
Strengths
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
- Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)
What to consider
- A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
- Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.